Sphincter of Oddi hypertonicity as a predictor of various gastrointestinal pathologies
https://doi.org/10.33667/2078-5631-2026-5-50-52
Abstract
The purpose of the study. Spasmolytics are the leading and most pathogenetically determined component of therapy for patients with biliary dysfunction. Mebeverine hydrochloride is the optimal choice in this case.
Materials and methods. This review analyzes the results of treatment of 120 patients with biliary dysfunction using the mebeverine hydrochloride.
Results and conclusion. Mebeverine hydrochloride has a beneficial effect on the process of bile excretion in patients with biliary dysfunction.
About the Authors
S. V. Sheloukhina
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Russian Federation
Sheloukhina Svetlana V., PhD Med Sci, assistant professor at Nursing Dept.
Ryazan
M. A. Butov
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Russian Federation
Butov Mikhail A., Dr Med Sci (habil.) professor, professor at Nursing Dept, Honored Doctor of the Russian Federation
Ryazan
I. A. Zagravskaya
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Russian Federation
Zagravskaya Irina A., PhD Med Sci, associate professor at Dept of Faculty Therapy named after professor V. Ya Garmash
Ryazan
E. V. Markova
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Russian Federation
Markova Elena V., PhD Med Sci, assistant professor at Nursing Dept.
Ryazan
O. A. Maslova
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Russian Federation
Maslova Olga A., PhD Med Sci, associate professor at Dept of Faculty Therapy named after professor V. Ya Garmash
Ryazan
A. S. Vasilevskaya
Ryazan State Medical University named after academician I. P. Pavlov
Russian Federation
Russian Federation
Vasilevskaya Anna S., PhD Med Sci, assistant at Dept of Propaedeutics of Internal Dseases
Ryazan
References
1. Lazebnik L. B., Golovanova E. V., Volel B. A., Korochanskaya N. V., Lyalyukova E. A., Mokshina M. V., Mekhtiev S. N., Mekhtieva O. A., Metsaeva Z. V., Petelin D. S., Simanenkov V. I., Sitkin S. I., Cheremushkin S. V., Chernogorova M. V., Khavkin A. I. Russian Scientifi c Medical Society of Therapists; Scientifi c Society of Gastroenterologists of Russia. Functional diseases of the digestive system. Crossover syndromes. Clinical guidelines. Experimental and Clinical Gastroenterology. 2021; 192 (8): 5–117. (In Russ.). DOI: 10.31146/1682–8658-ecg-192-8-5-117
2. Functional disorders of the biliary tract. Diagnostics. Treatment / Agafonova N. A., Yakovenko E. P., Yakovenko A. V., Ivanov A. N. Moscow: Anta Press, 2018. 35 p. (In Russ.). Available at https://medi.ru/info/27371
3. Pakhomova I. G. A patient with functional biliary disorder. Specificity of therapeutic management. RMJ. 2022; 3: 13–19. (In Russ.).
4. Menon S., Holt A., Farmer A. D. Intra-Sphincteric Botulinum Toxin in the Management of Functional Biliary Pain. Endosc. Int. Open. 2022; 10: E 521–E 527. https://doi.org/10.1055/a-1784-0061
5. Loranskaya I. D. Functional disorders of the biliary tract: [manual] / I. D. Loranskaya. M.: Forte print, 2013. 92 p. (In Russ.). ISBN 978-5-905757-27-3.
6. Simon D. A., Friesen C. A., Schurman J. V., Colombo J. M. Biliary Dyskinesia in Children and Adolescents: A Mini Review. Front Pediatr. 2020 Mar 24; 8: 122. https://doi.org/10.3389/fped.2020.00122
7. Stepanova E. V., Loranskaya I. D., Rakitskaya L. G., Mamedova L. D. Biliary dysfunctions. Efficiency of antispasmodic therapy // Effective pharmacotherapy. 2020; 16 (1): 62–68. (In Russ.).
8. Minushkin O. N. Biliary dysfunction: definition, diagnosis, treatment. Medical Council. 2015; 17: 88–95. (In Russ.).
9. Maev I. V., Samsonov A. A. Chronic duodenitis (Diagnostic and treatment strategy algorithm) / Manual for general practitioners, therapists, and gastroenterologists: Study guide. Moscow: State Educational Institution of Higher Scientific Medical Center of the Ministry of Health and Social Development of the Russian Federation, 2007. 80 p. (In Russ.).
10. Butov M. A. Propaedeutics of internal diseases: textbook. 2nd edition, revised and enlarged / M. A. Butov. Moscow: GEOTAR-Media, 2024. 584 p. (In Russ.).
11. Ivashkin V. T., Mayev I. V., Shulpekova Yu.O. et al. Diagnostics and treatment of biliary dyskinesia: clinical guidelines of the Russian gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28 (3): 63–80. (In Russ.). https://doi.org/10.22416/1382-4376-2018-28-3-63-80
12. Goloshubina V. V., Moiseyeva M. V., Bagisheva N. V. et al. Functional disorders of the biliary tract: actual aspects of diagnostics and treatment. RMJ. Medical Review. 2018; 3: 13–17. (In Russ.).
13. Medical Decision Support System. Gastroenterology: Clinical Treatment Protocols / Authors: D. S. Bordin, K. A. Nikolskaya, I. G. Bakulin [et al.]. Moscow: State Budgetary Institution «Research Institute of Health Protection of the City of Moscow», 2021. 136 p. (In Russ.).
14. Skvortsov V. V., Levitan B. N., Emelianov D. N. et al. Biliary Dyskinesia in Therapeutic Practice. Doctor. 2023; 34 (10): 28–35. (In Russ.). https://doi.org/10.29296/25877305-2023-10-05
Review
For citations:
Sheloukhina S.V., Butov M.A., Zagravskaya I.A., Markova E.V., Maslova O.A., Vasilevskaya A.S. Sphincter of Oddi hypertonicity as a predictor of various gastrointestinal pathologies. Medical alphabet. 2026;(5):50-52. (In Russ.) https://doi.org/10.33667/2078-5631-2026-5-50-52
Views:
69
JATS XML
Email this article 